Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × AML × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1098 Neoplasms 948 Carcinoma, Non-Small-Cell Lung 684 Prostatic Neoplasms 632 Colorectal Neoplasms 515 Lung Neoplasms 508 Pancreatic Neoplasms 359 Leukemia, Myeloid, Acute 350 Neoplasm Metastasis 337 Multiple Myeloma 331 Ovarian Neoplasms 322 Carcinoma, Hepatocellular 285 Stomach Neoplasms 282 Melanoma 261 Recurrence 254 Squamous Cell Carcinoma of Head and Neck 238 Brain Neoplasms 235 Lymphoma 217 Endometrial Neoplasms 216 Precursor Cell Lymphoblastic Leukemia-Lymphoma 215 Uterine Cervical Neoplasms 212 Triple Negative Breast Neoplasms 205 Head and Neck Neoplasms 205 Glioblastoma 200 Urinary Bladder Neoplasms 185 Sarcoma 185 Carcinoma, Renal Cell 182 Hematologic Neoplasms 179 Esophageal Neoplasms 177 Lymphoma, Non-Hodgkin 163

Interventions

ivosidenib 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting

AML

Data powered by HemOnc (CC BY 4.0) Colophon ⚡